<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="15033">Thioredoxin</z:chebi> (<z:chebi fb="0" ids="52292">TRX</z:chebi>) is a small, multifunctional protein with a redox-active site and multiple biological functions that include reducing activity for reactive oxygen intermediates </plain></SENT>
<SENT sid="1" pm="."><plain>We assayed <z:chebi fb="0" ids="52292">TRX</z:chebi> and <z:chebi fb="0" ids="52292">TRX</z:chebi> <z:chebi fb="2" ids="33699">mRNA</z:chebi> by immunohistochemical methods and hybridization experiments in the rat brain after middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) occlusion </plain></SENT>
<SENT sid="2" pm="."><plain>During <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, the immunoreactivity for <z:chebi fb="0" ids="52292">TRX</z:chebi> decreased; it disappeared after <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion in the ischemic regions </plain></SENT>
<SENT sid="3" pm="."><plain>It rapidly decreased and nearly disappeared at 4 and 16 hours after <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion in the lateral striatum and frontoparietal cortex, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>On the other hand, in the perifocal ischemic region, the penumbra, <z:chebi fb="0" ids="52292">TRX</z:chebi> immunoreactivity began to increase 4 hours after <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion and continued to increase until 24 hours after occlusion </plain></SENT>
<SENT sid="5" pm="."><plain>In hybridization experiments, <z:chebi fb="0" ids="52292">TRX</z:chebi> <z:chebi fb="2" ids="33699">mRNA</z:chebi> decreased and nearly disappeared 4 hours after <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion in the lateral striatum </plain></SENT>
<SENT sid="6" pm="."><plain>In the frontoparietal cortex, it decreased until 24 hours after <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion </plain></SENT>
<SENT sid="7" pm="."><plain>In the perifocal ischemic region, <z:chebi fb="0" ids="52292">TRX</z:chebi> <z:chebi fb="2" ids="33699">mRNA</z:chebi> began to increase 4 hours after <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion and continued to increase until 24 hours </plain></SENT>
<SENT sid="8" pm="."><plain>Northern blot analysis showed that total <z:chebi fb="0" ids="52292">TRX</z:chebi> <z:chebi fb="2" ids="33699">mRNA</z:chebi> in the operated hemispheres was induced from 8 hours and increased until 24 hours after the surgical procedures </plain></SENT>
<SENT sid="9" pm="."><plain>We previously reported that recombinant <z:chebi fb="0" ids="52292">TRX</z:chebi> promotes the in vitro survival of primary cultured neurons </plain></SENT>
<SENT sid="10" pm="."><plain>We now suggest that <z:chebi fb="0" ids="52292">TRX</z:chebi> in the penumbra has neuroprotective functions and that decreased levels of <z:chebi fb="0" ids="52292">TRX</z:chebi> in the ischemic core modify neuronal damage during focal <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
</text></document>